...
首页> 外文期刊>Indian Journal of Surgery >Management of Variceal Hemorrhage in Children with Extrahepatic Portal Venous Obstruction-Shunt Surgery Versus Endoscopic Sclerotherapy
【24h】

Management of Variceal Hemorrhage in Children with Extrahepatic Portal Venous Obstruction-Shunt Surgery Versus Endoscopic Sclerotherapy

机译:小儿肝外门静脉阻塞性分流术与内镜下硬化治疗的静脉曲张出血的处理

获取原文
获取原文并翻译 | 示例
           

摘要

Extrahepatic portal venous obstruction (EHPVO) is a common cause of portal hypertention in children. Esophageal variceal hemorrhage is a major cause of morbidity and mortality in these patients. For many decades, portal systemic shunts were considered as the most effective treatment of variceal hemorrhage. Endoscopic injection sclerotherapy (EIS) was first introduced for emergency management of bleeding varices and subsequently as definitive treatment to prevent recurrent hemorrhage. The purpose of the study was to compare the safety and efficacy of shunt surgery and endoscopic sclerotherapy for patients with proven esophageal variceal bleeding due to EHPVO. The study was a prospective randomized study of 61 children with bleeding esophageal varices due to EHPVO carried out jointly by the department of General Surgery and Gastroenterology at Sher-i-Kashmir Institute of Medical Sciences, Srinagar, between March 2001 and September 2003. Thirty patients received surgery and other 31 patients received EIS. Overall incidence of rebleeding was 22.6% in sclerotherapy group and 3.3% in shunt surgery group. Treatment failure occurred in 19.4% patients in sclerotherapy group and 6.7% in shunt surgery group. The rebleeding rate of sclerotherapy is significantly higher than that of shunt surgery. However, the therapy failure rate of sclerotherapy is not significantly different from that of shunt surgery.
机译:肝外门静脉阻塞(EHPVO)是儿童门静脉高压症的常见原因。食管静脉曲张破裂出血是这些患者发病和死亡的主要原因。数十年来,门静脉系统分流术被认为是治疗静脉曲张破裂出血最有效的方法。内镜注射硬化疗法(EIS)最初用于出血静脉曲张的紧急处理,随后作为预防复发出血的确定性治疗。这项研究的目的是比较经分流手术和内窥镜硬化疗法对因EHPVO导致食管静脉曲张破裂出血的患者的安全性和有效性。该研究是对61名因EHPVO引起的食管静脉曲张破裂出血的儿童进行的前瞻性随机研究,由斯利那加的谢里-克什米尔医学科学研究所普通外科和胃肠病学系于2001年3月至2003年9月之间进行。30例患者接受了手术,其他31例患者接受了EIS。硬化治疗组再出血的总发生率为22.6%,分流手术组为3.3%。硬化治疗组中有19.4%的患者发生治疗失败,而分流手术组中有6.7%的患者发生治疗失败。硬化疗法的再出血率明显高于分流手术。然而,硬化疗法的治疗失败率与分流手术没有明显差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号